Role of VEGF and CD44v6 in differentiating benign from malignant ascites

doi:10.3748/wjg.v9.i11.2596

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2103)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

198

HTML

1683

Figures (1-3)

107

Tables (1-1)

115

Sum=2103

Nov 15, 2003 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (33)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Nov 15, 2003; 9(11): 2596-2600
Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2596

Full Size Figure Download Figure

Figure 3 Concentrations of VEGF and sCD44v6 in different kinds of malignant ascites. Group A: ovarian cancer; Group B: gastric cancer; Group C: colon cancer. Concentrations of VEGF in group A were higher than those in groups B and C (P < 0.01), while the difference of CD44v6 levels among groups A, B and C was not statistically significant (P > 0.05).

Citation: Dong WG, Sun XM, Yu BP, Luo HS, Yu JP. Role of VEGF and CD44v6 in differentiating benign from malignant ascites. World J Gastroenterol 2003; 9(11): 2596-2600
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2596.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i11.2596